Browsing by Author "Yildiz, O."

Now showing 1 - 3 of 3

Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC?
(2019-01-01) Olmez, O. F.; Bilici, A.; Gursoy, P.; Cubukcu, E.; Yildiz, O.; Sakin, A.; Korkmaz, T.; Cil, I.; Cakar, B.; Menekse, S.; Demir, T.; Acikgoz, O.; Hamdard, J.
COST-EFFECTIVENESS OF SORAFENIB FOR TREATMENT OF RADIOACTIVE IODINE (RAI)-REFRACTORY LOCALLY ADVANCED/METASTATIC DIFFERENTIATED THYROID CANCER (DTC) IN TURKEY
(ELSEVIER SCIENCE INC, 2015-01-01) Erdal, E.; Sayman, H.; Turkmen, C.; Aral, F.; Yildiz, O.; Okutur, K.; Parali, E.; Deger, C.; Tunalioglu, A.; Sar, C.; Asan, S.; Sumer, F.; Ozel, O.
Systemic Inflammatory Markers as a Predictors of Response to Crizotinib in Patients with ALK-Positive Non-Small-Cell Lung Cancer
(2019-01-01) Bilici, A.; Olmez, O. F.; Gursoy, P.; Cubukcu, E.; Yildiz, O.; Sakin, A.; Korkmaz, T.; Cil, I.; Cakar, B.; Menekse, S.; Demir, T.; Acikgoz, O.; Hamdard, J.